CAR-NK cells: A promising cellular immunotherapy for cancer

CAR-NK cells: A promising cellular immunotherapy for cancer

Show other versions (1)

© 2020 The Author(s) Natural Killer (NK) cells and CD8+ cytotoxic T cells are two types of immune cells that can kill target cells through similar cytotoxic mechanisms. With the remarkable success of chimeric antigen receptor (CAR)-engineered T (CAR-T) cells for treating haematological malignancies,...

Full description

Bibliographic Details
Main Authors:	Xie, Guozhu, Dong, Han, Liang, Yong, Ham, James Dongjoo, Rizwan, Romee, Chen, Jianzhu
Format:	Article
Language:	English
Published:	Elsevier BV 2021
Online Access:	https://hdl.handle.net/1721.1/135407

Similar Items

CAR-NK cells: A promising cellular immunotherapy for cancer
by: Xie, Guozhu, et al.
Published: (2022)

Memory-like NK cells armed with a neoepitope-specific CAR exhibit potent activity against NPM1 mutated acute myeloid leukemia
by: Dong, Han, et al.
Published: (2022)

Utilizing Cytokines to Function-Enable Human NK Cells for the Immunotherapy of Cancer
by: Rizwan Romee, et al.
Published: (2014-01-01)

CAR-T cells targeting a nucleophosmin neoepitope exhibit potent specific activity in mouse models of acute myeloid leukaemia
by: Xie, Guozhu, et al.
Published: (2021)

CAR-T cells targeting a nucleophosmin neoepitope exhibit potent specific activity in mouse models of acute myeloid leukaemia
by: Xie, Guozhu, et al.
Published: (2022)

Repurposing anti-mesothelin CAR-NK immunotherapy against colorectal cancer
by: Erica Torchiaro, et al.
Published: (2024-12-01)

CAR-NK cells for gastrointestinal cancer immunotherapy: from bench to bedside
by: Xingwang Zhu, et al.
Published: (2024-10-01)

Editorial: Cancer immunotherapies for hematologic malignancies - NK/CIK/CAR-T perspective
by: Amit Sharma, et al.
Published: (2024-06-01)

CAR-NK cells for cancer immunotherapy: recent advances and future directions
by: Tianye Li, et al.
Published: (2024-02-01)

Beyond CAR-T: The rise of CAR-NK cell therapy in asthma immunotherapy
by: Mohadeseh Mohammad Taheri, et al.
Published: (2024-08-01)

Breakthrough of solid tumor treatment: CAR-NK immunotherapy
by: Wenkang Wang, et al.
Published: (2024-01-01)

ADAM17 and CD56lowCD16low NK cells
by: Rizwan Romee, et al.
Published: (2015-08-01)

Umbilical cord blood as a promising source of NK cells for immunotherapy
by: R. A. Velichinskii, et al.
Published: (2023-06-01)

An innovative single-cell approach for phenotyping and functional genotyping of CAR NK cells
by: Alaa Ali, et al.
Published: (2024-05-01)

RETRACTED: CAR-NK Cell: A New Paradigm in Tumor Immunotherapy
by: Faroogh Marofi, et al.
Published: (2021-06-01)

CAR immunotherapy in autoimmune diseases: promises and challenges
by: Jingjing Yu, et al.
Published: (2024-10-01)

Ovarian Cancer Ascites Inhibits Transcriptional Activation of NK Cells Partly through CA125
by: Fraser, Christopher C, et al.
Published: (2023)

The power and the promise of CAR-mediated cell immunotherapy for clinical application in pancreatic cancer
by: Hao-Yu Tang, et al.
Published: (2025-01-01)

Radiotherapy enhances the anti-tumor effect of CAR-NK cells for hepatocellular carcinoma
by: Xiaotong Lin, et al.
Published: (2024-10-01)

Thymic NK-Cells and Their Potential in Cancer Immunotherapy
by: Forbes C, et al.
Published: (2024-03-01)

Immunotherapy of B cell lymphoma with CD22-redirected CAR NK-92 cells
by: Xiaopeng Tian, et al.
Published: (2023-04-01)

CAR-macrophage: Breaking new ground in cellular immunotherapy
by: Ting Huang, et al.
Published: (2024-10-01)

Emerging roles of CAR-NK cell therapies in tumor immunotherapy: current status and future directions
by: Yan Zhong, et al.
Published: (2024-07-01)

CAR Macrophages: a promising novel immunotherapy for solid tumors and beyond
by: Jialin Lu, et al.
Published: (2024-08-01)

What’s in a name? Memory NK cells for cancer immunotherapy
by: William J Murphy, et al.
Published: (2025-01-01)

Promising Cellular Immunotherapy for Colorectal Cancer Using Classical Dendritic Cells and Natural Killer T Cells
by: Mahmoud Singer, et al.
Published: (2025-01-01)

CD28 is superior to 4-1BB costimulation in generating CAR-NK cells for tumor immunotherapy
by: Pengchao Zhang, et al.
Published: (2025-03-01)

NK cell-based tumor immunotherapy
by: Hao Zhang, et al.
Published: (2024-01-01)

CAR-NK cells in combination therapy against cancer: A potential paradigm
by: Junping Li, et al.
Published: (2024-03-01)

TRIP13: A promising cancer immunotherapy target
by: Shengnan Jing, et al.
Published: (2024-12-01)

Antitumor Immunity: Role of NK Cells and Extracellular Vesicles in Cancer Immunotherapy
by: Angelina E. Prokopeva, et al.
Published: (2023-12-01)

NK cells in renal cell carcinoma and its implications for CAR-NK therapy
by: Xinwei Li, et al.
Published: (2025-02-01)

Scalable process development of NK and CAR-NK expansion in a closed bioreactor
by: Xuening Wang, et al.
Published: (2024-07-01)

CAR-macrophages: tailoring cancer immunotherapy
by: Dewan Chettri, et al.
Published: (2025-01-01)

Advances in CAR-NK cell therapy for lung cancer: is it a better choice in the future?
by: Fengqin Liu, et al.
Published: (2024-05-01)

Correction: Emerging NK cell therapies for cancer and the promise of next generation engineering of iPSC-derived NK cells
Published: (2022-09-01)

Epigenetics and immunotherapy in colorectal cancer: progress and promise
by: Tianjiao Dang, et al.
Published: (2024-09-01)

Combinatorial immunotherapy with anti-ROR1 CAR NK cells and an IL-21 secreting oncolytic virus against neuroblastoma
by: Yaya Chu, et al.
Published: (2025-03-01)

Chimeric antigen receptor-natural killer (CAR-NK) cell immunotherapy: A bibliometric analysis from 2004 to 2023
by: Wangshu Li, et al.
Published: (2024-12-01)

Advances in bioengineered CAR T/NK cell therapy for glioblastoma: Overcoming immunosuppression and nanotechnology‐based strategies for enhanced CAR T/NK cell therapy
by: Nasim Dana, et al.
Published: (2025-03-01)